Full name
"BYDGOSKIE CENTRUM DIABETOLOGII I ENDOKRYNOLOGII W BYDGOSZCZY" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"BYDGOSKIE CENTRUM DIABETOLOGII I ENDOKRYNOLOGII W BYDGOSZCZY" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. KRZYSZTOFA KAMILA BACZYŃSKIEGO 17, 85-822 BYDGOSZCZ
TAX ID9532640791
Rate company:
"BYDGOSKIE CENTRUM DIABETOLOGII I ENDOKRYNOLOGII W BYDGOSZCZY" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9532640791
KRS0000482538
Share capital50,000.00 zł
address
UL. KRZYSZTOFA KAMILA BACZYŃSKIEGO 17, 85-822 BYDGOSZCZ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9532640791
REGON
341483508
KRS
0000482538
Legal form
limited liability company
Register Address
UL. KRZYSZTOFA KAMILA BACZYŃSKIEGO 17, 85-822 BYDGOSZCZ
Date of registration in KRS
2013-10-24
Date of commencement of economic activity
2013-10-24
Act signature
BY.XIII NS-REJ.KRS/13364/24/67/ADE
Pkd codes
86.22.Z - Specialist medical practice
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.60.Z - Educational support activities
86.21.Z - General medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
96.04.Z - Individual service activities
Payer VAT status
Active
Vat list bank account(s)
PL88 1020 1462 0000 7902 0409 8612 
PL40 1160 2202 0000 0002 4770 2194 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0 | -0,1 | 0,4 | 426,8 |
Gross profit (loss) | 0 | -0,1 | 0,4 | 469 |
EBITDA | 0,1 | -0 | 0,4 | 2063,7 |
Short time liabilities | 0,4 | 0,9 | 0,7 | -21 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 0,5 | 0,4 | 0,8 | 81,6 |
Operating profit (EBIT) | 0 | -0,1 | 0,4 | 468 |
Assets | 0,9 | 1,3 | 1,5 | 11 |
Net profit (loss) | 0 | -0,1 | 0,3 | 433,3 |
Cash | 0,2 | 0,4 | 0,4 | -3,8 |
Net income from sale | 3,7 | 4,8 | 6,3 | 29,8 |
Liabilities and provisions for liabilities | 0,4 | 0,9 | 0,7 | -21 |
Working assets | 0,6 | 1,1 | 1,3 | 16,8 |
Other income costs | 0 | 0 | 0 | -100 |
Depreciation | 0,1 | 0,1 | 0,1 | -24,2 |
% | % | % | p.p. | |
Profitability of capital | 4,2 | -24,6 | 45,1 | 69,7 |
Equity capital to total assets | 56,9 | 31,2 | 51,1 | 19,9 |
Gross profit margin | 0,7 | -2,1 | 6 | 8,1 |
EBITDA Margin | 3,1 | -0,5 | 7 | 7,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 36 | 70 | 42 | -28 |
Current financial liquidity indicator | 1.6770787239074707 | 1.227407455444336 | 1.814069151878357 | 0,6 |
Net dept to EBITDA | -1.016971468925476 | 18.377988815307617 | -0.9000583291053772 | -19,3 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download xml01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (9)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
BOGUMIŁA KĘPA Bogumiła Kępa
Świdnica
OrtoGo Centrum Medyczne Sp. z o.o.
Warszawa